Re-Examining the "High-Risk" Lean MASLD Paradigm: The Pivotal Confounding of Age and Catabolic State

Related Experiment Video

Updated: Jan 15, 2026

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

16.3K

Qianqian Wang1, Qin Zeng1, Yuxuan Chen1

  • 1The Second Affiliated Hospital of Zhejiang Chinese Medical University (Xinhua Hospital of Zhejiang Province), Hangzhou, China.

Journal of Gastroenterology and Hepatology
|October 11, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Hispanic paradoxlean individualsmajor adverse liver outcomes

More Related Videos

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography
07:33

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography

Published on: November 8, 2024

828
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.3K

Related Experiment Videos

Last Updated: Jan 15, 2026

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

16.3K
Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography
07:33

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography

Published on: November 8, 2024

828
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.3K

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

166
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
166

Articles linked to this work by shared authors, journal, and citation graph.

Real-time microscopic visualisation: current applications and challenges of confocal laser endomicroscopy in the diagnosis and treatment of small bowel disorders.

Therapeutic advances in gastroenterology·2026

Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome.

Immunology·2024

PARs in the inflammation-cancer transformation of CRC.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2022

IS1294 Reorganizes Plasmids in a Multidrug-Resistant Escherichia coli Strain.

Microbiology spectrum·2021

Exploring the thermodynamic, kinetic and inhibitory mechanisms of 5-iTU targeting mitotic kinase haspin by integrated molecular dynamics.

Physical chemistry chemical physics : PCCP·2021

TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway.

Journal of cellular and molecular medicine·2021

A Case With Longitudinal Changes in Apolipoprotein A2 Isoform Indices Associated With CA19-9 and MRI Findings Until Pancreatic Cancer Development.

Journal of gastroenterology and hepatology·2026

Clinical Prospect of Novel Therapies for Functional Cure in Chronic Hepatitis B.

Journal of gastroenterology and hepatology·2026

Clinical Application of Artificial Intelligence in the Management of Chronic Hepatitis B.

Journal of gastroenterology and hepatology·2026

Time-Dependent Mortality Risk in Lean Metabolic Dysfunction-Associated Steatotic Liver Disease During Long-Term Follow-Up.

Journal of gastroenterology and hepatology·2026

Longitudinal Gut Microbiota Changes in Mouse Models of Chronic Colitis, Colitis-Associated Cancer, and Chemotherapy-Induced Diarrhea.

Journal of gastroenterology and hepatology·2026

LC2767 Alleviates Cholestatic Liver Injury and Fibrosis in Bile Duct-Ligated Mice.

Journal of gastroenterology and hepatology·2026

Bacteroidota-derived glycine lipids differentially regulate skeletal muscle mitochondrial adaptation during Western diet feeding in male Ldlr-/- mice.

The Journal of physiology·2026

Multifaceted Physiological Roles of Lipoproteins and Understanding Atherosclerosis: Crosstalk Between Lipoproteins and Bioactive Lipids.

Journal of atherosclerosis and thrombosis·2026

Crosstalk along the gut-liver axis in liver disease: Clinical and mechanistic aspects.

Journal of hepatology·2026

Shugan Xiaozhi Formula Reduces Hepatic Steatosis and Stiffness in MASLD Patients with Elevated ALT: An Exploratory 24-Week Randomized Trial.

Pharmacological research·2026

Mechanistic insights into cholesterol-mediated MASH pathogenesis: Glycation, lipoxidation, and RAGE pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Emerging insights into PPARα's role in lean metabolic dysfunction-associated steatotic liver disease: Implications for targeted therapies.

Acta pharmaceutica Sinica. B·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us